Batholin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Batholin

Quick Facts

Property Description
Active ingredient Sulphamethoxazole and Trimethoprim
Form Tablet, Oral Suspension, Intravenous Solution
Pharmacological class Antibacterial (Sulfonamide/Dihydrofolate Reductase Inhibitor Combination)
Common use Treatment of various bacterial infections
Origin Synthetic

Batholin: A Synthetic Combination Antibiotic

Batholin is a synthetic medicine, known generically as Co-trimoxazole, which is a fixed-dose combination product containing two synergistic active ingredients. This drug is distinguished from single-agent antibiotics because it combines Sulphamethoxazole, a sulfonamide, and Trimethoprim, a dihydrofolate reductase inhibitor, to achieve its effect. This precise pairing is also known under common trade names such as Bactrim and Septra. The medicine belongs to the antimicrobial combination pharmacological class and is available in multiple dosage forms, including tablets for oral consumption, oral suspension for easier use in pediatric or specific patient groups, and solution for intravenous infusion (injection), providing diverse routes of administration as clinically necessary.


How the Dual Components Deliver its General Purpose

The general purpose of Batholin is to provide a potent and comprehensive strategy for the management of susceptible bacterial infections, such as those affecting the urinary tract. This effect is achieved because the combination of Sulphamethoxazole and Trimethoprim creates a powerful synergistic effect. This dual action sequentially blocks the bacteria's process of creating and utilizing folic acid, which is vital for their survival and replication. The medication works by effectively stopping the growth of bacteria, which functions as a powerful bactericidal agent for various types of infections. The combined formula is therefore used to target a wide spectrum of bacteria and aims to eliminate the microbe population causing the illness.

What side effects are possible with Batholin?

Possible Side Effects and Safety Information

The official safety information for Batholin focuses on a profile that includes both common local reactions and a very rare risk of serious, potentially disabling, and long-lasting systemic adverse reactions.

Serious and Disabling Adverse Reactions

Regulatory authorities have noted that this medicine carries a very rare risk of severe effects that may be persistent or potentially irreversible, primarily affecting two major system-organ classes:

  • Musculoskeletal System: Reactions include tendonitis (inflammation of the tendon) and tendon rupture (especially the Achilles tendon), arthralgia (joint pain), muscle weakness, and gait disturbance. These effects can occur within 48 hours of starting treatment but may also have a delayed onset of several months after the medicine is discontinued.
  • Nervous System: Documented effects include peripheral neuropathy (nerve damage, described as numbness or a “pins and needles” sensation), as well as central nervous system effects such as depression, anxiety, memory impairment, and disturbances in sleep, hearing, vision, taste, and smell.

Other Documented Adverse Reactions

Most reported adverse events are considered minor and local. These can include local signs and symptoms such as vaginal ulceration or maceration (softening and breakdown of the skin tissue). Hypersensitivity reactions, including urticaria, rash, and swelling, have also been documented in post-marketing reports.

Adverse Reaction Category Primary System-Organ Class Involved
Disabling/Irreversible Risks Musculoskeletal and Nervous Systems
Local Reactions Genital/Urinary System
Hypersensitivity Immune System/Skin

Safety-Related Restrictions and Contraindications

The regulatory profile mandates important safety restrictions. Treatment must be immediately discontinued at the first sign of a serious adverse reaction, such as tendon pain, inflammation, or any symptoms related to nerve damage (e.g., tingling or numbness). The medicine is officially contraindicated in patients who have a history of serious adverse reactions associated with this type of drug.

Overdose and Emergency Response

Overdose Manifestations and Severity

Official regulatory documents define Batholin overdose through documented manifestations affecting multiple systems. Acute presentations may include gastrointestinal signs such as nausea and vomiting, as well as neurological symptoms like confusion and dizziness. Severe acute toxicity may lead to seizures or convulsions. The regulatory labeling specifies that overdose carries the risk of life-threatening outcomes, such as severe blood dyscrasias (including aplastic anemia and agranulocytosis), fulminant hepatic necrosis, and dangerous hyperkalemia (high serum potassium). The trimethoprim component is specifically noted for its potential to cause acute bone marrow depression.

Required Emergency Actions

Immediate medical attention must be sought for any suspected overdose situation. Government guidance states that emergency services must be contacted immediately if the individual exhibits signs of collapse, troubled breathing, or a seizure. Furthermore, the medication should be discontinued immediately upon the first sign of a serious adverse reaction, such as a skin rash, to prevent severe, documented complications. Supportive management documented in official texts includes procedures like gastric lavage and the specific use of folinic acid (Leucovorin) to counteract the hematological effects of the trimethoprim overdosage. Hemodialysis is listed as a potential measure due to the drug’s moderate dialysability. Regulators note a heightened risk of severe reactions and toxicity in elderly patients and individuals with impaired renal function.

Therapeutic Uses of Batholin

What Batholin Treats: Main Uses and Benefits

Batholin (Co-trimoxazole) is commonly used to help treat a wide range of bacterial and opportunistic infections, contributing to symptomatic support across multiple therapeutic domains. This medication is used for easing symptoms in conditions like uncomplicated urinary tract infections (UTIs), severe forms of infectious diarrhea (e.g., Shigellosis), and acute exacerbations of chronic bronchitis.

Symptom Management and Clinical Scenarios

This medicine is applied across domains where the patient experiences symptoms related to acute inflammatory or irritative states, helping to ease the painful, frequent urges (dysuria) associated with bacterial infection. It is also considered relevant for symptomatic management of clusters of symptoms that interfere with daily functioning, such as those caused by severe infectious diarrhea or the worsening cough and fever linked to a respiratory flare-up. When applied in appropriate clinical settings, Batholin supports the patient during difficult episodes by easing distress and contributes to improved comfort during symptomatic periods.


Quick Fact: Symptom Support Overview

Symptom Category Therapeutic Use Patient Benefit
Genitourinary Distress Symptomatic management of uncomplicated UTIs Helps ease pain and urgency during urination.
Respiratory Symptoms Used in bacterial exacerbations of bronchitis Supports management of acute cough and fever burden.
Vulnerable Patients Treatment or prevention of serious opportunistic infections May assist with supporting functional stability.

Regulatory References

  1. SULFAMETHOXAZOLE AND TRIMETHOPRIM tablet - DailyMed - NIH

Eligibility and Restrictions for Use

Who Can and Cannot Use Batholin?

The population eligibility for Batholin (Co-trimoxazole) is strictly defined by regulatory authorities and centers on specific medical conditions, age, and organ function.

Contraindications (Must Not Use)

Condition / Population Eligibility Status
Known Hypersensitivity Contraindicated (to trimethoprim or sulfonamides)
Severe Organ Impairment Contraindicated (marked hepatic damage or severe renal insufficiency: CrCl < 15 mL/min)
Hematologic Status Contraindicated (megaloblastic anemia due to folate deficiency)
Infants Contraindicated (less than two months of age)

Use with Caution or Restriction

Batholin is approved for adults and children two months of age and older when no contraindications exist. However, use is restricted or conditional for several groups. Elderly patients require caution due to increased risk of severe adverse effects. Patients with intermediate renal impairment (CrCl 15 to 30 mL/min) require a dose reduction. Use is not recommended during the first trimester of pregnancy and is contraindicated at term. Additionally, use requires caution in patients with G6PD deficiency or those predisposed to folate deficiency.

What should I know about interactions with other medicines?

Certain combinations of Batholin (sulfamethoxazole and trimethoprim) with other medicinal products are restricted or require specific monitoring, as documented by regulatory authorities. The interaction profile is defined by both pharmacokinetic and pharmacodynamic effects.

Restrictions and Contraindicated Combinations

Co-administration with Dofetilide is strictly contraindicated due to a significant increase in its plasma concentrations, which raises the risk of life-threatening cardiac arrhythmia. The concurrent use of Methenamine is also contraindicated due to the risk of crystalluria. Additionally, the use of Leucovorin is restricted when managing Pneumocystis jirovecii pneumonia, as this specific combination is associated with therapeutic failure.

Pharmacokinetic and Pharmacodynamic Interactions

Batholin components can inhibit the metabolism of certain co-administered drugs. Co-administration with Warfarin can significantly potentiate its anticoagulant effect, requiring frequent Prothrombin Time (PT/INR) checks. Plasma levels of Phenytoin and Digoxin may also increase, an effect notably observed in the elderly population.

Trimethoprim can inhibit renal clearance transporters, leading to increased plasma concentrations and toxicity of drugs like Methotrexate. A pharmacodynamic interaction exists with ACE Inhibitors and Angiotensin Receptor Blockers (ARBs), increasing the documented risk of hyperkalemia (elevated potassium levels). Use with certain thiazide diuretics also carries an increased risk of thrombocytopenia, particularly in elderly patients. The components are less effectively cleared in patients with severe renal insufficiency, increasing the risk of adverse effects.

Mechanism of Action

How Batholin Works: Sequential Dual Blockade

The mechanism of Batholin (Co-trimoxazole) is a specific sequential dual blockade that targets the essential survival pathway of susceptible bacteria. This combination creates a synergistic effect that is greater than the sum of their individual activities.


Dual Inhibition of Bacterial Folate Synthesis

The drug's action begins by simultaneously blocking two crucial enzymes required for bacteria to synthesize Tetrahydrofolic Acid (THF), a coenzyme essential for bacterial metabolism. Sulphamethoxazole acts as a competitive inhibitor of Dihydropteroate Synthase (DHPS), preventing the initial step. Immediately downstream, Trimethoprim inhibits Dihydrofolate Reductase (DHFR), halting the conversion to active folate.


Cascading Blockade of DNA and Protein Production

The resulting severe depletion of THF forces a severe metabolic disruption within the bacterial cell. Since THF is necessary for synthesizing the building blocks of DNA (purines and thymidine) and certain proteins, the mechanism prevents the synthesis required for replication and repair. This cessation of life-essential functions results in a bactericidal effect (bacterial cell death) against susceptible organisms.

Dosage and Administration Information

How Batholin is Used: Administration Guidelines

Batholin (Co-trimoxazole) is administered through two routes: Oral (using tablets or oral suspension) and Intravenous Infusion. The specific method of administration and dosage are determined by the condition being addressed and the patient's clinical status.

Most acute infections are managed using a standard adult dosing schedule of one Double Strength (DS) tablet (800 mg Sulphamethoxazole / 160 mg Trimethoprim) administered every 12 hours. Treatment duration is typically a short course, such as 5 days for shigellosis or 10 to 14 days for uncomplicated urinary tract infections, though severe infections may require courses of up to 21 days.

Administration Contexts and Adjustments

Oral doses may be taken without regard to meals but must be swallowed with a full glass of water to ensure adequate fluid intake. The oral suspension must be shaken well before use.

For the Intravenous Infusion route, the concentrate must be diluted immediately before use and administered by slow infusion over 60 to 90 minutes; rapid injection or intramuscular administration is not permitted.

Crucially, dose modifications are mandatory for certain patient populations. For adults with moderate renal impairment, defined as a creatinine clearance (CrCl) between 15 and 30 mL/min, the dosage must be reduced by 50%. The medicine is generally not used in infants under two months of age, and pediatric dosing is calculated based on body weight or body surface area.

Recent Clinical Evidence

Research Evidence / Overview of studies for Batholin

Evidence for Use in Uncomplicated Urinary Tract Infections (UTIs)

Research exploring the use of Batholin in uncomplicated urinary tract infections includes Randomized Controlled Trials (RCTs) and systematic reviews. These studies were designed to explore how this medication was observed in non-pregnant adult women and various pediatric patient groups. The research examined short-term outcomes such as the resolution of patient-reported outcomes describing perceived discomfort (e.g., urgency and pain during urination) and the achievement of microbiological clearance, which is the eradication of the causative bacteria. Findings describe patterns observed in the studies related to the rate at which bacteria were cleared. Long-term effects regarding the prevention of infection recurrence are not fully established. Furthermore, the relevance of older study findings is examined in research because of the ongoing emergence of antimicrobial resistance patterns, which requires continuous monitoring.

Evidence for Use in Severe Infectious Diarrhea

The study context for severe infectious diarrhea, such as that caused by Shigella, involved Randomized Controlled Trials (RCTs) and observational cohort studies. The research was evaluated in specific populations, including adults, children, and travelers, to explore short-term symptom changes. These studies monitored outcomes related to physical discomfort by measuring the duration and quantified severity of diarrhea and the rate of fever resolution, alongside confirmation of microbiological clearance. Data show patterns related to the speed of acute symptom changes. However, the consistency of these research outcomes appears to depend on the specific type of pathogen and local resistance patterns, which can lead to findings being mixed across different geographical regions.

Evidence for Use in Preventing Opportunistic Infections

The available research, including long-term observational cohort studies and Randomized Controlled Trials (RCTs), explored research questions concerning the prevention and treatment of severe opportunistic infections (such as Pneumocystis pneumonia). This evidence was observed in highly specific patient groups, including immunocompromised individuals (like those with HIV/AIDS or transplant recipients). The research explored outcomes, including the prevention of primary infection or its recurrence and clinical endpoints such as hospitalization rates and overall survival. Findings indicate patterns related to the observed frequency of infection incidence or recurrence over long-term observation periods.

What is Still Uncertain About the Evidence for Batholin

Scientific literature and regulatory evaluations highlight several areas where research is ongoing or certainty remains low. A key limitation is that evidence quality varies across studies, and some follow-up durations were limited to the immediate treatment phase. The widespread and continually changing antimicrobial resistance of bacteria is a significant consideration that may alter the clinical relevance of older data. The findings describe group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Pneumocystis Pneumonia: Adult and Adolescent Opportunistic Infections - National Institutes of Health (NIH) Clinical Info Guidelines
  2. Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing - NICE Guideline NG114 (Summary of Evidence)
  3. The benefit of co-trimoxazole treatment in the management of acute watery diarrhea caused by invasive bacterial infection (RCT on Diarrhea)

Frequently Asked Questions (FAQ)

Common questions about Batholin (FAQ)

Q: Is Batholin available over the counter or do you need a prescription?

A: According to official regulatory sources, Batholin (Co-trimoxazole) is distributed under Prescribing Information. This means it is generally categorized as a prescription-only medication and is typically dispensed with the authorization of a licensed healthcare provider.

Q: How quickly should I expect to feel the effects of Batholin?

A: Regulatory patient information indicates that some individuals may begin to feel better during the first few days after starting the medication. To help ensure the infection is fully eradicated, it is important that the complete course of treatment is followed.

Q: Can elderly people generally take Batholin?

A: Official information indicates that Batholin may be used by the elderly, but particular care is advisable. Older patients are often more susceptible to certain side effects and may be considered for closer monitoring by a healthcare provider, particularly with pre-existing kidney or liver conditions.

Q: Is it okay to take Batholin with vitamin supplements?

A: Regulatory guidance advises patients to inform their healthcare provider about all substances they are taking. This includes all prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products, as some supplements may have the potential to interact with the medication.

Q: Does taking Batholin require any regular blood tests or monitoring?

A: Yes, official documents advise that if the medication is taken for long periods, or if a patient has a condition predisposing them to folate deficiency, regular monthly blood counts may be advised. Monitoring of kidney function may also be required in certain situations.

Q: Why is it important to take Batholin exactly as directed?

A: Regulatory patient information emphasizes that it is important to complete the entire course of antibiotics as prescribed. Stopping the medication too early, even if symptoms improve, is important to help prevent the risk of treatment failure or the development of resistance.

Q: Can children take Batholin, and if so, what are the general guidelines?

A: The medication is contraindicated for infants under two months of age. For children two months and older, the dose is generally calculated based on their body weight or body surface area, and is typically prescribed to be given in divided doses throughout the day.

Q: Is Batholin safe for people who are allergic to certain medications?

A: The medicine is contraindicated (meaning it should not be used) if a patient has a known allergy or hypersensitivity to sulfamethoxazole, trimethoprim, or any medicines belonging to the sulfonamide class. Patients should always discuss their allergy history with a doctor before treatment.

Q: Is Batholin generally considered safe for pregnant or breastfeeding individuals?

A: Official information states that the medication is not recommended during the first three months of pregnancy and is contraindicated (must not be used) at term. Regulatory information states that during breastfeeding, it is contraindicated if the infant is under two months of age or has certain risk factors, as noted in the drug label.

Q: Is it normal to feel a slight headache when first starting Batholin?

A: Official patient information leaflets list headache as a common side effect associated with the use of Batholin. If this symptom becomes severe or does not resolve, it should be discussed with a healthcare professional.

Q: How long does the effect of a single dose of Batholin typically last?

A: The components of Batholin are eliminated from the body slowly. The mean serum half-lives (the time it takes for half the drug to be eliminated) are approximately 10 hours for sulfamethoxazole and 8 to 10 hours for trimethoprim, which supports its typical dosing schedule.

Q: Does Batholin cause drowsiness or affect driving ability?

A: Regulatory warnings indicate that Batholin may cause sleepiness, confusion, or dizziness in some individuals. If a patient experiences these effects, official warnings advise against driving or operating machinery until the patient understands how the medication affects them.

Q: Is Batholin safe for long-term use?

A: The medication is primarily prescribed for short-course infections, but regulatory documents discuss situations where it is given for long periods. When used long-term, regular monthly blood counts and folate monitoring are typically recommended due to increased risk of certain adverse effects.

Q: Why do some people experience mild stomach upset when taking Batholin?

A: Gastrointestinal disturbances, such as nausea and vomiting, are listed in official documents as common side effects. Taking the medicine with food or a small snack is sometimes suggested to help minimize these effects.

Q: What steps should be taken if a dose of Batholin is missed?

A: General patient advice indicates that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should typically be omitted and the regular schedule continued.

Q: Are there any known interactions between Batholin and herbal remedies?

A: Yes, official regulatory information advises that a patient should inform their healthcare provider about all medications they are taking, including any herbal and complementary medicines, as there is a potential for these to interact with Batholin.

Q: Is it true that Batholin can be used for more than one condition?

A: Yes. Regulatory documents state that the product is indicated for the treatment or prevention of various types of infections. These include urinary tract infections, lung infections, severe infectious diarrhea, and certain opportunistic infections.

Q: What should I do if I think I'm experiencing a rare side effect of Batholin?

A: Official patient information advises that if a patient experiences signs of a serious reaction, such as a severe rash, swelling, or difficulty breathing, they should seek emergency medical treatment or call a doctor immediately.

Q: Does Batholin interact with hormonal contraceptives?

A: Regulatory and supporting clinical data suggest a potential for interaction with oral contraceptive steroids, specifically noting an increase in the plasma concentration of a component often found in these contraceptives. Patients taking hormonal contraceptives are advised to review this information with a healthcare provider.

Q: How soon after stopping Batholin will it be completely out of my system?

A: The elimination half-lives of the components are approximately 8 to 10 hours. Since it takes several half-lives for a drug to be fully excreted, the medication is typically cleared from the body within two to three days after the final dose.

Q: Are there any lifestyle changes recommended when taking Batholin?

A: Yes, regulatory patient guidance typically advises patients to maintain adequate fluid intake throughout the day while taking the medicine. There is also a warning to limit unnecessary or prolonged exposure to sunlight due to the risk of photosensitivity (increased skin sensitivity to sun).

Q: Can a person take Batholin while recovering from surgery?

A: Yes. Official regulatory documents indicate that the medication, especially the Intravenous Injection form, is used to treat and prevent pre- and post-operative infections that may be associated with surgery, trauma, or gynaecological procedures.

Q: Are there any specific warnings about driving or operating machinery while on Batholin?

A: Official warnings exist stating that if the medicine causes side effects like dizziness, confusion, or sleepiness, patients must be cautious and avoid driving or operating any heavy machinery until these effects have passed.

Q: Is the effectiveness of Batholin affected by diet or exercise?

A: Regulatory information states the medication can generally be taken with or without food without affecting its action. However, a healthcare provider should be aware of a patient's diet, as there is a warning about the co-administration of potassium-rich foods with certain interacting drugs.

Q: Can I stop taking Batholin suddenly, or does it require tapering?

A: Official advice states that a patient should not stop the antibiotic course midway, even if they feel better, as this may not clear the infection. The need for a tapering schedule should be determined by a healthcare provider.

Q: Does Batholin interact with common over-the-counter cold and flu medicines?

A: While regulatory guidance confirms that some common cold medicine components may not have known interactions, patients are always advised to inform their doctor of all over-the-counter medications they are taking. This allows a healthcare provider to determine if any potentially risky combinations are present.

How should Batholin be stored and disposed of?

Storage and Disposal Requirements

Batholin (Co-trimoxazole) must be stored according to regulatory guidelines to ensure product stability.

Storage Conditions

Requirement Specific Condition
Temperature Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
Container Must be kept in a tightly closed, light-resistant container.
Environment The product must be protected from excess heat and moisture.
Child Safety Mandatory to keep the medication out of the sight and reach of children.

Disposal Instructions

Unused or expired Batholin should be disposed of through a medicine take-back program or a regulated drug disposal process. The medication should not be flushed down the toilet or poured into a drain unless specific instruction is provided, ensuring compliance with local and national pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Batholin found in:

A-Z Index: